ã€ä¸–ç•ŒãŒæ³¨ç›®ã™ã‚‹æ”¾å°„性医薬å“é ˜åŸŸã§ã‚»ãƒ©ãƒŽã‚¹ãƒ†ã‚£ã‚¯ã‚¹ã‚’åŠ é€Ÿã•ã›ã‚‹ãƒ¡ãƒ‡ã‚£ã‚«ãƒ«ãƒªãƒ¼ãƒ€ãƒ¼ã¨ã—ã¦ä»¥ä¸‹ãŠä»»ã›ã—ã¾ã™ã€‚ ■新薬群ã®ãƒ¡ãƒ‡ã‚£ã‚«ãƒ«ãƒ—ランã€ãƒ‘ブリケーションプランç‰ã®ç–定・実施 â– å…±åŒç ”究（IIS/IIT）ã€è¦³å¯Ÿç ”究ã€RWEç ”ç©¶ã®ä¼ç”»ãƒ»æ”¯æ´...
ãŒæ³¨ç›®ã™ã‚‹æ”¾å°„性医薬å“é ˜åŸŸã§ã‚»ãƒ©ãƒŽã‚¹ãƒ†ã‚£ã‚¯ã‚¹ã‚’åŠ é€Ÿã•ã›ã‚‹ãƒ¡ãƒ‡ã‚£ã‚«ãƒ«ãƒªãƒ¼ãƒ€ãƒ¼ã¨ã—ã¦ä»¥ä¸‹ãŠä»»ã›ã—ã¾ã™ã€‚ ■新薬群ã®ãƒ¡ãƒ‡ã‚£ã‚«ãƒ«ãƒ—ランã€ãƒ‘ブリケーションプランç‰ã®ç–定・実施 â– å…±åŒç ”究（IIS/IIT）ã€è¦³å¯Ÿç ”究ã€RWEç ”ç©¶ã®ä¼ç”»ãƒ»æ”¯æ´ãƒ»ç®¡ç†ç‰ã«ã‚ˆã‚‹ã‚¨ãƒ“デンス創出 ■アドãƒã‚¤ã‚¶ãƒªãƒ¼ãƒœãƒ¼ãƒ‰ç‰ã«ã‚ˆã‚‹KOLã¨ã®ç§‘å¦çš„コミュニケーションã€ã‚¢ãƒ³...
Lugar:
Tokyo | 13/03/2026 03:03:55 AM | Salario: S/. No Especificado
ã‚’è¡Œã£ã¦ã„ã¾ã™ã€‚ æ¥å‹™å†…容 今ã€ä¸–ç•ŒãŒæ³¨ç›®ã™ã‚‹æ”¾å°„性医薬å“é ˜åŸŸã§ã‚»ãƒ©ãƒŽã‚¹ãƒ†ã‚£ã‚¯ã‚¹ã‚’åŠ é€Ÿã•ã›ã‚‹ãƒ¡ãƒ‡ã‚£ã‚«ãƒ«ãƒªãƒ¼ãƒ€ãƒ¼ã¨ã—ã¦ä»¥ä¸‹ãŠä»»ã›ã—ã¾ã™ã€‚ 新薬群ã®ãƒ¡ãƒ‡ã‚£ã‚«ãƒ«ãƒ—ランã€ãƒ‘ブリケーションプランç‰ã®ç–定・実施 å…±åŒç ”究（IIS/IIT）ã€è¦³å¯Ÿç ”究ã€RWEç ”ç©¶...
RWE Renewables Japan G.K. To start as soon as possible, full time, permanent This role covers regulatory affairs... responsibilities for RWE's activities in Japan. Based in Tokyo, the role focuses on understanding, engaging with, and communicating...
Lugar:
Tokyo | 06/03/2026 21:03:37 PM | Salario: S/. No Especificado | Empresa:
RWE evidence (RWE) research, post-market safety studies, medical affairs publications to maximize the value of our products... of protocols, analysis plans and analysis execution and interpretation for RWE research and post-market safety studies. ï¬Provide...
Lugar:
Hyogo | 05/03/2026 18:03:08 PM | Salario: S/. No Especificado | Empresa:
Eli Lilly）10年以上 ・メディカルプランç–定・実行ã€ãƒ‘ブリケーション戦略ã€ã‚¨ãƒ“デンス創出（IIS/RWE）ã«æ·±ã関与ã—ãŸçµŒé¨“ ・KOLエンゲージメントã€ã‚¢ãƒ‰ãƒã‚¤ã‚¶ãƒªãƒ¼ãƒœãƒ¼ãƒ‰é‹å–¶ãªã©ã®å®Ÿè·µçµŒé¨“ ・組織・ãƒãƒ¼ãƒ ã®ãƒžãƒã‚¸ãƒ¡ãƒ³ãƒˆçµŒé¨“（人数ä¸å•ï¼è‚²æˆ...
Lugar:
Tokyo | 04/03/2026 03:03:45 AM | Salario: S/. 9000000 - 12000000 per year
that are not addressed via Clinical Trials (CTs) for the relevant business function and their planning of Real World Evidence (RWE... of regulatory frameworks for Japan (e.g., J-GCP), including trial requirements for registration/approval, acceptance of RWE...
［仕事詳細］ ã€ECサイトé‹å–¶ã€‘ 当社ã§ã¯é«˜ç´šè…•æ™‚計やブランドå“を扱ã†Webサイト・ECショップã®é‹å–¶ã‚¹ã‚¿ãƒƒãƒ•ã‚’募集ã—ã¦ã„ã¾ã™â€¼ ï¼¼ï¼²ï¼·ï¼¥æ ªå¼ä¼šç¤¾ã£ã¦ã©ã‚“ãªä¼šç¤¾ï¼Ÿï¼ ・ãƒãƒ¬ãƒƒã‚¯ã‚¹ã€ãƒ‘テックフィリップã€ã‚«ãƒ«...支給致ã—ã¾ã™! IMPERIAL å…¬å¼ã‚µã‚¤ãƒˆ https://rwe-imperial.com/ IMPERIAL æ¥½å¤©å¸‚å ´åº— https://www.rakuten.co.jp/rwe-imperial/ ［交通］ 地下鉄上å‰æ´¥é§…å¾’æ©3分 地下...
Lugar:
Aichi | 27/02/2026 03:02:07 AM | Salario: S/. No Especificado
World Evidence (RWE) generation and input to Asset Evidence Plan(AEP). G6: When needed, deputize Japan Evidence Lead... of regulatory frameworks for Japan (e.g., J-GCP), including trial requirements for registration/approval, acceptance of RWE...
/pre-clinical researches, external collaborative research and RWE (Real World Evidence) studies. ・Contribution to benefit...